NEW YORK, November 20, 2018 – Northeast Business Group on Health (NEBGH) today released “Genomic Medicine and Employers: Separating the Hope from Hype,” the industry’s first employer guide to help HR and benefits leaders better understand and make coverage decisions about genomic medicine and genetic testing.
According to the National Human Genome Resource Institute, genomic medicine is an emerging medical discipline that uses genomic information about an individual for diagnostic or therapeutic decision-making. Genomic medicine is most commonly applied in oncology, pharmacology, cardiology, rare and undiagnosed diseases, infectious disease, maternal health and mental health. While many treatments based on genomic research are still years away, when it comes to screening and diagnostic testing, marketplace progress in genomics is happening quickly..
Labeling a cancer diagnosis one of the most complex issues faced by employees and employers alike, Northeast Business Group on Health (NEBGH) today launched “Improving the Cancer Patient Experience: Putting Employees at the Center of Your Cancer Benefits Strategy,” a guide designed to help HR and benefits leaders organize, coordinate and provide the best possible experience for employees and family members with cancer..